secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2021-11-22T23:59:59+00:00
Accession:  0001213900-21-061032
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma announces $7M share repurchase program
-----------------------------------------------------

- Board authorized up to $7M of common stock repurchases.
- Cash and equivalents totaled $73.8M as of Sept 30, 2021.
- Approximately 11.2M shares outstanding as of Oct 29, 2021.
- CEO states program reflects confidence in pipeline and platform.
- Repurchases may occur on open market or privately; program can be modified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000121390021061032/0001213900-21-061032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000121390021061032/ea151173-8k_lantern.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-061032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer